![Nick Yeo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
Nick Yeo is currently the Chief Operating Officer at Veryan Medical Ltd.
He previously worked as a Director at Touchstone Innovations Ltd.
and as a Principal at Ernco 200 LTD.
Posizioni attive di Nick Yeo
Società | Posizione | Inizio |
---|---|---|
Veryan Medical Ltd.
![]() Veryan Medical Ltd. BiotechnologyHealth Technology Veryan Medical Ltd. develops and commercializes novel vascular stent technology. The firm's products are designed to clinical performance and bio-mechanical performance of stented vessels. The company was founded by Colin G. Caro, Charles Richard Taylor and Paul Burke Gilson in 2003 and is headquartered in Oxford, the United Kingdom. | Direttore operativo | - |
Precedenti posizioni note di Nick Yeo
Società | Posizione | Fine |
---|---|---|
Ernco 200 LTD
![]() Ernco 200 LTD Pharmaceuticals: MajorHealth Technology Ernco 200 LTD manufactured pharmaceutical Foscan for cancer treatment, specializes in photodynamic therapy. The company was headquartered in Stirling, the United Kingdom. | Corporate Officer/Principal | - |
TOUCHSTONE INNOVATIONS PLC | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
Veryan Medical Ltd.
![]() Veryan Medical Ltd. BiotechnologyHealth Technology Veryan Medical Ltd. develops and commercializes novel vascular stent technology. The firm's products are designed to clinical performance and bio-mechanical performance of stented vessels. The company was founded by Colin G. Caro, Charles Richard Taylor and Paul Burke Gilson in 2003 and is headquartered in Oxford, the United Kingdom. | Health Technology |
Touchstone Innovations Ltd.
![]() Touchstone Innovations Ltd. Investment ManagersFinance Touchstone Innovations Ltd. engages in the provision of technology and commercialization services. The company was founded by Susan Jane Searle in 1986 and is headquartered in London, the United Kingdom. | Finance |
Ernco 200 LTD
![]() Ernco 200 LTD Pharmaceuticals: MajorHealth Technology Ernco 200 LTD manufactured pharmaceutical Foscan for cancer treatment, specializes in photodynamic therapy. The company was headquartered in Stirling, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Nick Yeo